-+ 0.00%
-+ 0.00%
-+ 0.00%

Saniona submits FDA application to test SAN2465 for depression

PUBT·10/20/2026 06:08:59
Listen to the news
Saniona submits FDA application to test SAN2465 for depression
  • Saniona submitted an investigational new drug application to the FDA for SAN2465 to treat major depressive disorder.
  • A Phase 1 trial in healthy volunteers is expected to begin by year-end 2026, subject to FDA clearance.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Saniona AB published the original content used to generate this news brief on October 20, 2026, and is solely responsible for the information contained therein.